On the other hand, TipDCs (TNF-alpha/iNOS/NO producers) could be a potential immunotherapeutic target since it has been described that partial blocking of these cells protects against bacterial infections by priming CD8+ killer T cells [20–22]. This evidence concerns the gene CD8A and bacterial infectious disease.